Jennifer L Good's Net Worth

$873 Thousand

Estimate Recalculated Apr 16, 2024 07:13PM EST

Who is Jennifer L Good?

Jennifer L Good does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., XTL BIOPHARMACEUTICALS LTD, Trevi Therapeutics, Inc., JUNIPER PHARMACEUTICALS INC, and PENWEST PHARMACEUTICALS CO.

SEC CIK

Jennifer L Good's CIK is 0001229245

Past Insider Trading and Trends

2005 was Jennifer L Good's most active year for acquiring shares with 7 total transactions. Jennifer L Good's most active month to acquire stocks was the month of January. 2005 was Jennifer L Good's most active year for disposing of shares, totalling 10 transactions. Jennifer L Good's most active month to dispose stocks was the month of August. 2006 saw Jennifer L Good paying a total of $1,133,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2010 Jennifer L Good cashed out on 425,994 shares for a total of $856,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 19
Form 3
—
0
—
—
0
No matching records found

XTL BIOPHARMACEUTICALS LTD (XTLB) Snapshot price: $0.9131

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Trevi Therapeutics, Inc. (TRVI) Snapshot price: $1.46

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Sep 19
Form 4
—
0
—
—
0
Jun 29
Form 4/A
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Feb 17
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Jun 3
Form 4
+16.76%
29.6K
$10.00
—
206.2K
May 9
Form 3
—
0
—
—
0
No matching records found

JUNIPER PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-15.00K
$11.50
-$172,500.00
0
Aug 14
Form 4
∞
15K
—
—
15K
Sep 7
Form 3
—
0
—
—
0
No matching records found

PENWEST PHARMACEUTICALS CO No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
-100.00%
-60.99K
—
—
0
Sep 20
Form 4
+139.20%
25K
$1.56
$39,000.00
42.96K
Apr 28
Form 4
—
0
—
—
0
Mar 5
Form 4
+76.00%
7.5K
$2.14
$16,050.00
17.37K
Nov 11
Form 4
—
0
—
—
0
Mar 5
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Feb 9
Form 4
-25.42%
-2.00K
$11.72
-$259,928.86
5.87K
Dec 2
Form 4
—
0
—
—
0
Nov 23
Form 4
—
0
$11.71
-$6,295.00
7.87K
Oct 3
Form 4
—
0
$11.78
-$110,813.49
7.87K
Sep 7
Form 4
—
0
$10.16
-$32,311.69
7.87K
Aug 22
Form 4
+34.09%
2K
$5.41
$10,820.00
7.87K
Mar 24
Form 4
—
0
—
—
0
Feb 16
Form 4
+61.73%
2K
$5.41
$10,820.00
5.24K
Feb 23
Form 4
—
0
—
—
0
Feb 11
Form 4
+210.53%
2K
$5.41
$10,820.00
2.95K
Dec 2
Form 4
—
0
$13.58
-$190,381.38
0
Sep 11
No matching records found